ID: MRFR/HC/6890-CR | 169 Pages | Author: Rahul Gotadki | March 2022
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF DYSLEXIA
4.2.2 INCREASING APP DEVELOPMENT ACTIVITIES TO TREAT DYSLEXIA
4.2.3 GROWING NUMBER OF VITUAL REALITY-BASED EDUCATIONAL SOFTWARE
4.3 RESTRAINT
4.3.1 LACK OF AWARENESS ABOUT DYSLEXIA, ITS SYMPTOMS AND UNDERDIAGNOSIS
4.4 OPPORTUNITY
4.4.1 COLLABORATION WITH SCHOOLS, COLLEGES AND NON PROFIT ORGANIZATIONS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 RESEARCH & DEVELOPMENT
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION
5.1.4 MARKETING & SALES
5.1.5 POST-SALES MONITORING
5.1.6 INPUTS
5.1.7 SOFTWARE DEVELOPMENT PROCESSES
5.1.8 OUTPUT
5.1.9 MARKETING AND DISTRIBUTION
5.1.10 POST-SELLING SERVICES
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF BUYERS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19
5.4 DYSLEXIA DIAGNOSIS
5.5 DYSLEXIA TREATMENT
5.6 STANDARD PAPER TESTS VS ELECTRONIC VERSIONS
5.6.1 TESTS FOR DYSLEXIA AND LEARNING DISABILITIES (PRE-SCHOOLERS)
6 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET BY TYPE
6.1 OVERVIEW
6.2 PHONOLOGICAL DYSLEXIA
6.3 SURFACE DYSLEXIA
6.4 OTHERS
7 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET BY TREATMENT & DIAGNOSIS
7.1 OVERVIEW
7.2 TREATMENT
7.2.1 MEDICATIONS
7.2.1.1 ANTIHISTAMINES
7.2.1.2 CENTRAL NERVOUS STIMULANT
7.2.1.3 ANTI-MYOCLONIC
7.2.1.4 ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG
7.2.1.5 OTHERS
7.2.2 TOOLS
7.2.2.1 E-READERS AND TABLETS
7.2.2.2 APPS
7.2.2.3 SMARTPENS
7.2.2.4 OTHERS
7.3 DIAGNOSIS
7.3.1 PAPER-BASED
7.3.2 DIGITAL-BASED
8 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET BY END USER
8.1 OVERVIEW
8.2 SPECIALTY CENTER
8.3 HOME CARE
8.4 HOSPITALS & CLINICS
8.5 OTHERS
9 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST
9.5.3 AFRICA
10 COMPETITIVE LANDSCAPE
10.1 COMPETITIVE OVERVIEW
10.2 MAJOR PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET
10.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL DYSLEXIA TREATMENT MARKET
10.4 COMPETITIVE BENCHMARKING
10.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL DYSLEXIA TREATMENT MARKET
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES
10.6.2 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS
10.7 MAJOR PLAYERS FINANCIAL MATRIX
10.7.1 REVENUE OF MAJOR PLAYERS, 2020
10.7.2 R&D EXPENDITURE, 2020
11 COMPANY PROFILES
11.1 PFIZER INC.
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 SPEECHIFY INC.
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS.
11.2.5 KEY STRATEGIES
11.3 JUBILANT PHARMA LIMITED
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIES
11.4 LINGIT AS
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 SOLI
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 NOVARTIS AG
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS/SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 LYFTA
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS/SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 GLAXOSMITHKLINE
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 ELI LILLY & COMPANY
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES
11.11 RPG LIFE SCIENCES LTD
11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL OVERVIEW
11.11.3 PRODUCTS/SERVICES OFFERED
11.11.4 KEY DEVELOPMENTS
11.11.5 KEY STRATEGIES
11.12 HOPALAI D.O.O.
11.12.1 COMPANY OVERVIEW
11.12.2 FINANCIAL OVERVIEW
11.12.3 PRODUCTS/SERVICES OFFERED
11.12.4 KEY DEVELOPMENTS
11.12.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 APPLICATION DEVELPOPED SPECIFICALLY FOR DYSLEXIA
TABLE 4 FREE APPS FOR DYSLEXIA
TABLE 5 DYSLEXIA SCHOOLS IN CANADA
TABLE 6 DYSLEXIA SCHOOLS IN THE UK
TABLE 7 DYSLEXIA SCHOOLS IN THE UK
TABLE 8 DYSLEXIA AND LEARNING DISABILITIES TESTS FOR PRE-SCHOOLERS (BIRTH – 5 YEARS):
TABLE 9 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY SHOULDER TYPE, 2023-2032 (USD MILLION)
TABLE 10 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY PHONOLOGICAL DYSLEXIA, 2023–2032 (USD MILLION)
TABLE 11 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR SURFACE DYSLEXIA, BY REGION, 2023–2032 (USD MILLION)
TABLE 12 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2023–2032 (USD MILLION)
TABLE 13 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)
TABLE 14 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY REGION, 2023–2032 (USD MILLION)
TABLE 15 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 16 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATIONS, BY REGION, 2023–2032 (USD MILLION)
TABLE 17 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 18 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR ANTIHISTAMINES, BY REGION, 2023–2032 (USD MILLION)
TABLE 19 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR CENTRAL NERVOUS STIMULANT, BY REGION, 2023–2032 (USD MILLION)
TABLE 20 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR ANTI-MYOCLONIC, BY REGION, 2023–2032 (USD MILLION)
TABLE 21 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG, BY REGION, 2023–2032 (USD MILLION)
TABLE 22 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2023–2032 (USD MILLION)
TABLE 23 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY REGION, 2023–2032 (USD MILLION)
TABLE 24 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 25 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR E-READERS AND TABLETS, BY REGION, 2023–2032 (USD MILLION)
TABLE 26 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR APPS, BY REGION, 2023–2032 (USD MILLION)
TABLE 27 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR SMARTPENS, BY REGION, 2023–2032 (USD MILLION)
TABLE 28 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2023–2032 (USD MILLION)
TABLE 29 COMMON CLINICAL TESTS PERFORMED TO DIAGNOSE DYSLEXIA
TABLE 30 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY REGION, 2023–2032 (USD MILLION)
TABLE 31 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 32 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR PAPER-BASED, BY REGION, 2023–2032 (USD MILLION)
TABLE 33 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIGITAL-BASED, BY REGION, 2023–2032 (USD MILLION)
TABLE 34 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)
TABLE 35 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR SPECIALTY CENTER, BY REGION, 2023–2032 (USD MILLION)
TABLE 36 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR HOME CARE, BY REGION, 2023–2032 (USD MILLION)
TABLE 37 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2023–2032 (USD MILLION)
TABLE 38 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2023–2032 (USD MILLION)
TABLE 39 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY REGION, 2023–2032 (USD MILLION)
TABLE 40 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY COUNTRY, 2023–2032 (USD MILLION)
TABLE 41 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 42 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 43 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 44 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)
TABLE 45 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 46 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 47 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 48 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 49 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 50 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 51 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)
TABLE 52 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 53 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 54 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 55 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 56 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 57 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 58 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)
TABLE 59 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 60 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 61 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 62 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)
TABLE 63 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)
TABLE 64 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)
TABLE 65 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)
TABLE 66 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 67 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 68 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)
TABLE 69 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)
TABLE 70 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)
TABLE 71 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)
TABLE 72 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)
TABLE 73 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 74 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 75 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)
TABLE 76 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)
TABLE 77 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)
TABLE 78 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)
TABLE 79 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)
TABLE 80 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 81 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 82 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)
TABLE 83 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)
TABLE 84 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)
TABLE 85 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)
TABLE 86 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)
TABLE 87 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 88 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 89 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)
TABLE 90 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)
TABLE 91 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)
TABLE 92 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)
TABLE 93 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)
TABLE 94 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 95 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 96 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)
TABLE 97 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)
TABLE 98 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)
TABLE 99 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)
TABLE 100 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)
TABLE 101 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 102 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 103 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)
TABLE 104 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)
TABLE 105 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)
TABLE 106 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)
TABLE 107 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)
TABLE 108 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 109 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)
TABLE 110 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)
TABLE 111 ASIA PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY COUNTRY, 2023–2032 (USD MILLION)
TABLE 112 ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 113 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 114 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 115 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 116 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)
TABLE 117 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 118 ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 119 CHINA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 120 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 121 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 122 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 123 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)
TABLE 124 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 125 CHINA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 126 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 127 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 128 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 129 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 130 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)
TABLE 131 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 132 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 133 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 134 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 135 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 136 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 137 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)
TABLE 138 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 139 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 140 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 141 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 142 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 143 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 144 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)
TABLE 145 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 146 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 147 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 148 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 149 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 150 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 151 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)
TABLE 152 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 153 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 154 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 155 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 156 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 157 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 158 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)
TABLE 159 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 160 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 161 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY COUNTRY, 2023–2032 (USD MILLION)
TABLE 162 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 163 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 164 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 165 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)
TABLE 166 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 167 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 168 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 169 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 170 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 171 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 172 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)
TABLE 173 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 174 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 175 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 176 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 177 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 178 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 179 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)
TABLE 180 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 181 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 182 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 183 AFRICA: DYSLEXIA TREATMENT MARKET, BY TYPE, 2023–2032 (USD MILLION)
TABLE 184 AFRICA: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)
TABLE 185 AFRICA: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)
TABLE 186 AFRICA: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)
TABLE 187 AFRICA: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 188 AFRICA: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)
TABLE 189 AFRICA: DYSLEXIA TREATMENT MARKET, BY END USER, 2023–2032 (USD MILLION)
TABLE 190 MAJOR PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET
TABLE 191 THE MOST ACTIVE PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET
TABLE 192 NEW PRODUCT DEVELOPMENTS/LAUNCHES/PRODUCT LICENSING AGREEMENTS
TABLE 193 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS
TABLE 194 PFIZER INC.: PRODUCTS OFFERED
TABLE 195 SPEECHIFY INC.: PRODUCTS OFFERED
TABLE 196 JUBILANT PHARMA LIMITED: PRODUCTS/SERVICES OFFERED
TABLE 197 LINGIT AS: PRODUCTS OFFERED
TABLE 198 LINGIT AS: KEY DEVELOPMENTS
TABLE 199 SOLI: PRODUCTS/SERVICES OFFERED
TABLE 200 NOVARTIS AG: PRODUCTS/SERVICES OFFERED
TABLE 201 LYFTA: PRODUCTS/SERVICES OFFERED
TABLE 202 LYFTA: KEY DEVELOPMENTS
TABLE 203 GLAXOSMITHKLINE: PRODUCTS OFFERED
TABLE 204 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED
TABLE 205 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS
TABLE 206 ELI LILLY & COMPANY: PRODUCTS/SERVICES OFFERED
TABLE 207 RPG LIFE SCIENCES LTD: PRODUCTS/SERVICES OFFERED
TABLE 208 HOPALAI D.O.O.: PRODUCTS/SERVICES OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET STRUCTURE: DYSLEXIA TREATMENT & DIAGNOSIS MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: DYSLEXIA TREATMENT & DIAGNOSIS MARKET
FIGURE 5 DRIVERS: IMPACT ANALYSIS
FIGURE 6 RESTRAINT: IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN: GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET
FIGURE 8 VALUE CHAIN: GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET
FIGURE 9 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET
FIGURE 10 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2020 & 2032 (USD MILLION)
FIGURE 11 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2020 & 2032 (USD MILLION)
FIGURE 12 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2020 & 2032 (USD MILLION)
FIGURE 13 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET SHARE (%), BY REGION, 2020
FIGURE 14 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 15 ASIA PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 16 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 17 EXPANSION: THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET
FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 19 REVENUE OF MAJOR PLAYERS, 2020
FIGURE 20 MAJOR PLAYERS R&D EXPENDITURE, 2020
FIGURE 21 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 PFIZER INC.: SWOT ANALYSIS
FIGURE 23 JUBILANT PHARMA LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 NOVARTIS AG: SWOT ANALYSIS
FIGURE 26 GLAXOSMITHKLINE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 GLAXOSMITHKLINE: SWOT ANALYSIS
FIGURE 28 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS
FIGURE 30 ELI LILLY & COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ELI LILLY & COMPANY: SWOT ANALYSIS
FIGURE 32 RPG LIFE SCIENCES LTD.: FINANCIAL OVERVIEW SNAPSHOT
Market Segmentation
Dyslexia Treatment Type Outlook (USD Billion, 2019-2030)
Phonological Dyslexia
Surface Dyslexia
Others
Dyslexia Treatment, Treatment & Diagnosis Outlook (USD Billion, 2019-2030)
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Dyslexia Treatment End User Outlook (USD Billion, 2019-2030)
Specialty Center
Home Care
Hospitals & Clinics
Others
Dyslexia Treatment Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
North America Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
North America Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
North America Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
US Outlook (USD Billion, 2019-2030)
US Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
US Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
US Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Canada Outlook (USD Billion, 2019-2030)
Canada Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Canada Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Canada Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Europe Outlook (USD Billion, 2019-2030)
Europe Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Europe Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Europe Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Germany Outlook (USD Billion, 2019-2030)
Germany Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Germany Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Germany Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
France Outlook (USD Billion, 2019-2030)
France Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
France Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
France Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
UK Outlook (USD Billion, 2019-2030)
UK Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
UK Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
UK Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Italy Outlook (USD Billion, 2019-2030)
Italy Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Italy Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Italy Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Spain Outlook (USD Billion, 2019-2030)
Spain Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Spain Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Spain Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Rest Of Europe Outlook (USD Billion, 2019-2030)
Rest Of Europe Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Rest of Europe Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Rest of Europe Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Asia-Pacific Outlook (USD Billion, 2019-2030)
Asia-Pacific Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Asia-Pacific Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Asia-pacific Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
China Outlook (USD Billion, 2019-2030)
China Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
China Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
China Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Japan Outlook (USD Billion, 2019-2030)
Japan Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Japan Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Japan Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
India Outlook (USD Billion, 2019-2030)
India Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
India Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
India Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Australia Outlook (USD Billion, 2019-2030)
Australia Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Australia Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Australia Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
South Korea Outlook (USD Billion, 2019-2030)
South Korea Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
South Korea Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
South Korea Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Rest of Asia-Pacific Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Rest of Asia-Pacific Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Rest of the World Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Rest of the World Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Middle East Outlook (USD Billion, 2019-2030)
Middle East Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Middle East Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Middle East Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Africa Outlook (USD Billion, 2019-2030)
Africa Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Africa Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Africa Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Latin America Outlook (USD Billion, 2019-2030)
Latin America Dyslexia Treatment by Type
Phonological Dyslexia
Surface Dyslexia
Others
Latin America Dyslexia Treatment by Treatment & Diagnosis
Treatment
Medications
Antihistamines
Central Nervous Stimulant
Anti-Myoclonic
Attention-Deficit Hyperactivity Disorder (ADHD), Drug
Others
Tools
E-readers and tablets
Apps
Smartpens
Others
Diagnosis
Paper-Based
Digital-Based
Latin America Dyslexia Treatment by End User
Specialty Center
Home Care
Hospitals & Clinics
Others
Research Methodology on Dyslexia Treatment Market
The research methodology used for Market Research Dyslexia Treatment Market Report is based on primary and secondary research. Primary research included interviews with dyslexia specialists and medical professionals who work with individuals with dyslexia. Secondary research involves collecting data from journals, books, and other published research and studies on dyslexia; analysis of media reporting on the topic; as well as interviews with industry experts.
Primary Research:
Primary research is conducted through semi-structured interviews with specialists and medical professionals who specialize in treating individuals with dyslexia. Interviewees are made up of both adult and child specialists and medical professionals who are knowledgeable about the market and trends for dyslexia treatments. They asked questions about the current trends, market drivers, and challenges, as well as their overall view of the market for dyslexia treatments. The research team also interviewed experts from the dyslexia research community, as well as technicians at dyslexia treatment centres.
Secondary Research:
Secondary research is used to compile a comprehensive look at the dyslexia treatment market. Information is gathered using a variety of sources, including studies and reports on dyslexia and related fields, reports of governmental organizations, business journals, trade magazines and websites, databases, company websites, and other related sources. All information is verified by a separate team of researchers to ensure the accuracy and reliability of the results.
Data Analysis:
The data collected through primary and secondary research is analyzed to provide an in-depth understanding of the dyslexia treatment market. The research team used a qualitative and quantitative approach to analyze the data. Qualitative analysis is used to gain an understanding of the market forces and trends, along with the key players in the industry. Quantitative analysis is used to develop a forecast from 2023 to 2030 for the dyslexia treatment market and to look ahead to the future market situation.
Assumptions:
The assumptions used in the research are based on examination and discussion with industry experts and stakeholders. The key assumptions are as follows: